Global T-cell Therapy Market to Grow at 16.9% During 2022-2027, Impelled by Rising Incidences of Cancer

May 21, 2021

According to the latest report by IMARC Group, titled "T-cell Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global T-cell therapy market is expected to exhibit a CAGR of 16.9% during 2022-2027. T-cell refers to a form of immunotherapy that involves the use of the patient’s own immune cells to treat cancer. This transfer therapy improves the functioning of the T-cells that are further employed to fight against cancer cells present in the patient’s body. This approach consists of the collection of immune cells that undergo re-engineering within a laboratory and are then injected back into the body of the individual. These re-engineered cells can recognize and kill cancer cells as they are equipped with targeted antigens on their surface. This method is widely gaining prominence among patients and healthcare professionals as it assists in targeting cancer cells in a precise manner.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Global T-cell Therapy Market Trends:

The global market is primarily driven by the increasing incidences of cancer on the global level. This can be accredited to the rising consumption of tobacco products, sedentary lifestyles led by the masses and their shifting dietary preferences toward unhealthy foods. Additionally, the growing geriatric population and a considerable rise in the prevalence of bone marrow and blood-forming tissue diseases are providing an impetus to the demand for T-cell therapy. The market is further driven by the growing awareness regarding the availability of innovative cancer treatments, such as T-cell therapy, among the masses. Moreover, the increasing number of T-cell therapies that are undergoing clinical studies is also creating a positive outlook for the market. For instance, the development of an off-the-shelf transfer therapy approach, which involves collecting immune cells from healthy donors to make them available for immediate use, is in the pipeline. The approval of such innovative therapies by the concerned regulatory bodies is expected to act as a major growth-inducing factor. Besides this, the United States Food and Drug Administration (USFDA) has approved the use of T-cell therapies for the treatment of acute lymphoblastic leukemia (ALL) and advanced lymphomas among children and adults simultaneously. This, along with the extensive research and development (R&D) activities conducted by the key players, is expected to provide a thrust to the market growth.

Market Summary:

  • On the basis of the modality, the market has been bifurcated into research and commercialized.
  • Based on the therapy type, the market has been classified into car t-cell based, t cell receptor (TCR) based, and tumor infiltrating lymphocytes (TIL) based.
  • On the basis of the indication, the market has been divided into hematologic malignancies (lymphoma, leukemia and myeloma), solid tumors (melanoma, brain and central nervous system, liver cancer, and others) and others.
  • On the geographical front, the market has been segregated into North America (the United States and Canada), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others), Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia and others), Latin America (Brazil, Mexico and others), and Middle East and Africa.
  • The competitive landscape of the market has been studied in the report with the detailed profiles of the key players. Some of these players include Amgen Inc., Aurora Biopharma Inc., bluebird bio Inc, Bristol-Myers Squibb Company, Fate Therapeutics, Gilead Sciences Inc., Merck KGaA, Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Pfizer Inc., Sorrento Therapeutics Inc., and TCR2 Therapeutics.

 

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us

IMARC Group

USA: +1-631-791-1145
Email: sales@imarcgroup.com
Website: https://www.imarcgroup.com
Follow us on twitter: @imarcglobal

Global T-cell Therapy Market to Grow at 16.9% During 2022-2027, Impelled by Rising Incidences of Cancer
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More